Yes there is a bit of cash but problem is that admin costs, directors fees etc are reducing it at an alarming rate
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025